
Advanced Quad-Peptide Blend
Four Peptides, Four Pathways: The Most Complete Regenerative Formula
KLOW combines four powerful peptides — BPC-157, TB-500, KPV, and GHK-Cu — into a single advanced research formulation. This quad blend targets tissue repair, angiogenesis, inflammation control, and cellular regeneration through complementary mechanisms. By uniting these compounds, KLOW provides the most comprehensive platform for regenerative research available.
- Quad-peptide synergy: BPC-157 + TB-500 + KPV + GHK-Cu
- 80mg total peptide per vial (10mg + 10mg + 10mg + 50mg)
- Four distinct but complementary repair pathways
- Enhanced anti-inflammatory action with KPV addition
- Streamlined protocols vs. sourcing four separate compounds

Quad-Mechanism Action
How Four Peptides Create Synergistic Regeneration
Each peptide in KLOW targets a specific phase of the healing cascade. BPC-157 drives angiogenesis and growth factor signaling. TB-500 (full 43-amino-acid Thymosin Beta-4) promotes cell migration and cytoskeletal remodeling. KPV — an α-MSH fragment — calms overactive immune signaling with potent anti-inflammatory and antimicrobial effects. GHK-Cu stimulates collagen production and tissue remodeling at the genetic level.
- BPC-157: Angiogenesis, cytoprotection, gut lining repair
- TB-500: Actin regulation, cell migration, wound healing
- KPV: Anti-inflammatory, antimicrobial, immune modulation
- GHK-Cu: Collagen synthesis, 4,000+ gene modulation
- Combined action across all stages of tissue repair

Research Applications
From Inflammation Control to Multi-System Regeneration
KLOW's unique quad-peptide design supports research across the broadest range of regenerative applications. The addition of KPV particularly enhances studies involving inflammatory conditions — from autoimmune research to gut barrier integrity. Combined with the tissue repair capabilities of the other three peptides, KLOW enables comprehensive healing pathway investigations.
- Inflammatory and autoimmune pathway research
- Gastrointestinal integrity and gut healing studies
- Tendon, ligament, and muscle repair modeling
- Wound healing and skin regeneration research
- Antimicrobial peptide activity investigations
- Comparative studies: quad vs. triple vs. single peptide

The Science Behind Quad-Peptide Synergy: Why KLOW Is the Ultimate Regenerative Platform
KLOW represents the most advanced peptide blend for regenerative research — combining four proven compounds into a single, synergistic formulation. While triple blends like GLOW offer significant advantages over single peptides, KLOW takes this further by adding KPV's powerful anti-inflammatory and antimicrobial properties.
The science behind each component is well-established. BPC-157 promotes angiogenesis, fibroblast activity, and gastrointestinal protection through growth factor signaling. TB-500 (the full 43-amino-acid Thymosin Beta-4 peptide) regulates actin — a key protein for cell movement — enabling repair cell migration to injury sites. GHK-Cu modulates over 4,000 genes related to tissue growth, collagen production, and cellular repair.
The KPV addition is what sets KLOW apart. This tripeptide fragment of α-melanocyte-stimulating hormone (α-MSH) reduces overactive immune signaling by suppressing pro-inflammatory cytokines and NF-κB activation. It also demonstrates antimicrobial activity — making KLOW particularly relevant for research involving infection, gut barrier dysfunction, or inflammatory conditions.
Together, these four peptides create an optimal healing environment: enhanced blood flow (BPC-157 + TB-500), controlled inflammation (KPV), and organized tissue remodeling (GHK-Cu). For research teams seeking the most comprehensive regenerative platform available, KLOW delivers four mechanisms in one streamlined formulation.
For research use only. Not for human consumption.
Scientific Literature
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JS. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011;110(3):774-80.
- Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157-NO-system relation. Curr Pharm Des. 2014;20(7):1126-35.
- Safer D, Elzinga M, Nachmias VT. Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem. 1991;266(7):4029-32.
- Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432(7016):466-72.
- Pickart L, et al. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108.
- Bossak-Ahmad K, et al. Ternary Cu(II) Complex with GHK Peptide and L-Urocanic Acid as a Potential Physiologically Functional Copper Chelate. Int J Mol Sci. 2020;21(17):6190.
- Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-78.
- Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(3):324-31.
- Brzoska T, et al. Terminal signal: anti-inflammatory effects of alpha-melanocyte-stimulating hormone related peptides beyond the pharmacophore. Adv Exp Med Biol. 2010;681:107-16.
Packaged with care, shipped fast.
We’re a passionate team obsessed with quality, not margins.
- Company
- Price
- Purity
- Quantity
- Shipping
-
Klow – 80mg
-
Prime
Lab PeptidesTypical
Competitor -
$135.00$245.00
- ≥99%95%
- 80mg80mg
- Free 2-Day Shipping3-10 Business Day
-